COI
PFE icon

Capital One Investing’s Pfizer PFE Stock Holding History

Capital One Investing’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$237K Hold
6,952
– – 0.06% 183
2019
Q2 		$286K Buy
+6,952
New +$276K 0.07% 148
2019
Q1 		– Sell
-4,999
Closed -$207K – 188
2018
Q4 		$207K Buy
+4,999
New +$208K 0.07% 137

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Capital One Investing's PFE Position: Q3 2019 in Review

Capital One Investing held its Pfizer (PFE) position steady in Q3 2019 at 6,952 shares worth $237K. The position accounts for 0.06% of the portfolio, ranked #183.

Capital One Investing first reported a position in PFE in Q4 2018 and has held it in 3 quarters since. The position peaked at $286K in Q2 2019. 2,323 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • Capital One Investing held 6,952 shares of Pfizer worth $237K as of Q3 2019.
  • Capital One Investing left its Pfizer share count unchanged in Q3 2019.
  • Pfizer made up 0.06% of Capital One Investing's portfolio in Q3 2019, its #183 holding.
  • Capital One Investing first reported a position in Pfizer in Q4 2018 and has held it in 3 quarters since.
  • Capital One Investing's Pfizer position peaked at $286K in Q2 2019.
  • 2,323 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Capital One Investing's 13F filing for Q3 2019, filed 14 Nov 2019.